Adam Golebiowski

5PUBLICATIONS
41CO-AUTHORS
Molecular targetsBiologically active moleculesCancer therapy (excl. chemotherapy and radiation therapy)Cheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 06, 2026
Structure-Guided Discovery of OAT-4828 as Potent, Selective, and Orally Bioavailable USP7 Inhibitor with In Vivo Antileukemic Activity.

|Mar 20, 2023
Arginase 1/2 Inhibitor OATD-02: From Discovery to First-in-man Setup in Cancer Immunotherapy.

Bartlomiej Borek, Julita Nowicka, Anna Gzik

|Oct 20, 2020
Discovery of OATD-01, a First-in-Class Chitinase Inhibitor as Potential New Therapeutics for Idiopathic Pulmonary Fibrosis.

Robert Koralewski, Barbara Dymek, Marzena Mazur

|Jul 11, 2019
Development of Dual Chitinase Inhibitors as Potential New Treatment for Respiratory System Diseases.

Marzena Mazur, Barbara Dymek, Robert Koralewski

|Dec 29, 2017
Targeting Acidic Mammalian chitinase Is Effective in Animal Model of Asthma.

Marzena Mazur, Jacek Olczak, Sylwia Olejniczak

Pageof 1

Frequent Collaborators

4 joint publications

Jacek Olczak

2 joint publications

Michał Piotrowicz

2 joint publications

Marcin Nowotny

2 joint publications

Bartlomiej Borek